MedPath
NMPA Approval

Naxitamab Injection

国药准字SJ20220019

November 30, 2022

Drug Information

那西妥单抗注射液

DANYELZA

注射剂

40mg(10mL)/瓶

生物制品

November 30, 2022

November 29, 2027

Company Information

Applicant Company

230 Park Avenue, Suite 3350, New York, NY 10169, USA

Manufacturing Company

5900 Martin Luther King Jr. HWY, Greenville, NC 27834, USA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

那西妥单抗注射液 - NMPA 批准文号 | MedPath